Business Development Advisor @ (January 2025 - Present)
Advisor @ (October 2024 - December 2024)
Chief Digital and Information Officer @ (November 2022 - September 2024)
COO (JUVO - Steward Business Solutions) @ Steward Health Care (December 2021 - November 2022)
SVP Informatics, Steward Health Care Network @ Steward Health Care (December 2019 - November 2022)
Senior Advisor @ Navigant (acquired by Guidehouse) (December 2018 - September 2019)
CEO and President, Member of the Board @ Otsuka Digital Health (subsidiary of Otsuka America Inc.) (October 2015 - June 2018)
Vice President, Global Commercialization and Portfolio Management @ (May 2014 - October 2015)
CEO and Board of Directors @ Pathonomics (University of Pennsylvania spinoff) (January 2013 - January 2014)
Venture Partner and Advisor @ Mansa Capital (January 2012 - January 2014)
President and CEO | Board of Directors @ (January 2008 - January 2012)
Vice President of Global Marketing, Gynecology, Urology and Oncology (Organon) @ (January 2006 - January 2008)
Global Marketing Lead, Virology @ (January 2003 - January 2006)
Director Portfolio Management @ Pharmacia (acquired by Pfizer) (January 2001 - January 2003)
Co-founder and COO @ LogonHealth (January 1999 - January 2001)
Michael Jarjour Education
Massachusetts Institute of Technology
No-Code AI & Machine Learning
Columbia University
Executive Program
Rutgers Business School
MBA (Finance)
Florida International University - College of Business
Bachelor of Business Administration (BBA) (Finance, General)
Michael Jarjour Skills
Biotechnology
Business Development
Business Strategy
Capital Raising
Clinical Development
Clinical Trials
Commercialization
Competitive Analysis
Competitive Intelligence
Cross-functional Team Leadership
Dermatology
Enterprise Software
Executive Management
Global Marketing
Healthcare
Healthcare Executive Leadership
Hospitals
Infectious Diseases
Leadership
Life Sciences
Lifesciences
Managed Care
Management
Market Access
Marketing
Medical Devices
Mergers
Mergers
Oncology
Pharmaceutical Industry
Pharmaceutical Sales
Product Launch
Product Management
Sales Effectiveness
Start-ups
Strategic Alliances
Strategic Partnerships
Strategic Planning
Strategy
Subsidiary Stand Up
Therapeutic Areas
Urology
Venture Capital
Cross-functional Team...
Cross Functional Team Leadership
Start Ups
Positioning
Thailand
Europe
Market
Screening
Strategic Insights
Infrastructure
Insurance
Expenses
Arabic
Territories
Medicare
Sales
Bacterial
Jump
Clinical Research
Sales Operations
Netherlands
Immunology
Finance
Articulating
Structure
Franchising
Honor
Return on Investment
Driving
Executive Positions
Miami
Hepatitis C
Distributorships
Generic Programming
Programming
Redesigning
Historic Preservation
RNA
Sales and Marketing
Temporary Placement
HMO
Market Growth
Segmentation
Assessment
Disease
Line Extensions
Florida
Trademarks
Revenue
Pathogens
German
Privatization
Short
Mature
Long Range
HIV
Integration
Medicaid
Programmers
Committees
Spanish
Coordinated
Pfizer
Boston
Publications
Latin
Public Speaking
Pennsylvania
Execution
Results Oriented
Cardiovascular
Profit
Philadelphia
Guidance
Networking
Physicians
Portfolio Management
Languages
System
Business Services
English
Food Safety
Staff Management
Voice
Virology
Caliber
In Licensing
Asia
Asset Allocation
Product Rationalization
Organizational Restructuring
Internet Protocols
Branding
Fortune 100
Formulary
Cloud Based
Strategies
Medicine
Sales Promotion
Buying
Financial Goals
Policy
Pre Launch
Solution
Scripting
Private Equity
Re Launch
Streamline
American
Research
Reporting
Shares
Capital
Commercial Real Estate
Microsoft
R&d
Board of Directors
Partnerships
Written
P&l
Information Technology
Business Partnering
Promotional
Jersey
NPV
Yahoo
C
Viruses
Space
Tissue
Early Development
Accountability
Applications
Business Expansion
Human Services
IV
DNA
Vast
Advertising
Business Operations
Ireland
Licensing
Operations
Out Licensing
Microarray
CMS
Mid Size
Strategic Investments
High Growth Companies
Gynecology
Pharmacy Benefit Management
Pipelines
Business Alliances
Project
Microsoft Partner
Contractual Agreements
Market Share
Healthcare Management
IPO
Cup
Pricing
Responsibility
Internal Audit
Packaging
Fortune
Regulations
Roadmap
International
Sybase
Google Groups
Growing Businesses
Portfolio
Reimbursement
Brazil
Hepatitis
New York
Gold
Government
Affiliates
Investments
Cork
Commercial Planning
Diagnostics
Subsidiaries
Materials
Shaping
Software
Product Design
Margin Improvement
Product Lifecycle Management
Sequence
Business Planning
Phase
India
Pharmaceutics
Asset
Compelling
Platforms
Symposia
Formulation
Central Nervous System
SaaS
Greece
Wireless
French
Mergers and Acquisitions
Anticipation
Michael Jarjour Summary
Michael Jarjour, based in United States, is currently a COO Healthcare Technologies at HWL. Michael Jarjour brings experience from previous roles at Secondwave Delivery Systems, CareMax, Inc. and Steward Health Care. Michael Jarjour holds a No-Code AI & Machine Learning @ Massachusetts Institute of Technology. With a robust skill set that includes Biotechnology, Business Development, Business Strategy, Capital Raising, Clinical Development and more. Michael Jarjour has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Michael Jarjour?
Find contact details for 700 million professionals.